IL82972A - Fused hybrid cell from mammalian or plant cells said fusion being facilitated by agglutination - Google Patents

Fused hybrid cell from mammalian or plant cells said fusion being facilitated by agglutination

Info

Publication number
IL82972A
IL82972A IL82972A IL8297287A IL82972A IL 82972 A IL82972 A IL 82972A IL 82972 A IL82972 A IL 82972A IL 8297287 A IL8297287 A IL 8297287A IL 82972 A IL82972 A IL 82972A
Authority
IL
Israel
Prior art keywords
agglutination
mammalian
fusion
facilitated
plant cells
Prior art date
Application number
IL82972A
Other languages
English (en)
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL82972A publication Critical patent/IL82972A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/14—Plant cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/59—Lectins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
IL82972A 1986-06-24 1987-06-23 Fused hybrid cell from mammalian or plant cells said fusion being facilitated by agglutination IL82972A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87809286A 1986-06-24 1986-06-24

Publications (1)

Publication Number Publication Date
IL82972A true IL82972A (en) 1991-06-30

Family

ID=25371360

Family Applications (1)

Application Number Title Priority Date Filing Date
IL82972A IL82972A (en) 1986-06-24 1987-06-23 Fused hybrid cell from mammalian or plant cells said fusion being facilitated by agglutination

Country Status (13)

Country Link
EP (1) EP0251107A3 (de)
JP (1) JPS633787A (de)
KR (1) KR880000581A (de)
CN (1) CN87104365A (de)
AU (1) AU600281B2 (de)
DK (1) DK319687A (de)
FI (1) FI872788L (de)
HU (1) HUT44078A (de)
IL (1) IL82972A (de)
NO (1) NO872630L (de)
NZ (1) NZ220766A (de)
PT (1) PT85151B (de)
ZA (1) ZA874410B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA874409B (en) * 1986-06-24 1988-04-27 Merrell Dow Pharma Fusion method
EP0401271B1 (de) * 1988-02-18 1996-04-17 Ks Biomedix Ltd. Antigen gegen diabetes
US6632976B1 (en) 1995-08-29 2003-10-14 Kirin Beer Kabushiki Kaisha Chimeric mice that are produced by microcell mediated chromosome transfer and that retain a human antibody gene
CA2230759C (en) * 1995-08-29 2012-02-21 Kirin Beer Kabushiki Kaisha Chimeric animal and method for producing the same
EP1305410B1 (de) * 2000-08-02 2005-10-12 UUTECH Limited Durch elektrofusion hergestellte insulin-produzierende zellinie
US9249385B1 (en) 2014-12-18 2016-02-02 City University Of Hong Kong System and method for fusing cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5825440B2 (ja) * 1980-12-30 1983-05-27 株式会社林原生物化学研究所 ヒトカルシトニンの製造方法
JPS5825439B2 (ja) * 1980-12-30 1983-05-27 株式会社林原生物化学研究所 ヒト副甲状腺ホルモンの製造方法
JPS6030654B2 (ja) * 1980-12-31 1985-07-17 株式会社林原生物化学研究所 ヒトコロニ−刺激因子の製造方法
JPS59169492A (ja) * 1983-03-15 1984-09-25 Asahi Chem Ind Co Ltd ヒト融合細胞からの生理活性物質の産生方法
US4806476A (en) * 1983-09-08 1989-02-21 Lovelace Medical Foundation Efficient cell fusion process
WO1987005929A1 (en) * 1986-04-01 1987-10-08 Genelabs Incorporated Immortalized cells which produce tissue-specific products
ZA874409B (en) * 1986-06-24 1988-04-27 Merrell Dow Pharma Fusion method

Also Published As

Publication number Publication date
JPS633787A (ja) 1988-01-08
NO872630D0 (no) 1987-06-23
DK319687D0 (da) 1987-06-23
EP0251107A2 (de) 1988-01-07
EP0251107A3 (de) 1989-10-04
NZ220766A (en) 1990-05-28
AU7451587A (en) 1988-01-07
AU600281B2 (en) 1990-08-09
CN87104365A (zh) 1988-02-03
FI872788A0 (fi) 1987-06-23
NO872630L (no) 1987-12-28
FI872788A7 (fi) 1987-12-25
HUT44078A (en) 1988-01-28
PT85151B (pt) 1990-03-30
KR880000581A (ko) 1988-03-28
PT85151A (en) 1987-07-01
ZA874410B (en) 1988-04-27
FI872788L (fi) 1987-12-25
DK319687A (da) 1987-12-25

Similar Documents

Publication Publication Date Title
GB2208750B (en) Solid electrolyte fuel cells
AU556166B2 (en) Improved solar cell
GB2134317B (en) Solid electrolyte fuel cell
GB2154051B (en) Organic electrolyte for nonaqueous cells
DE3171611D1 (en) High temperature solid electrolyte fuel cell configurations
GB2082599B (en) Gamma radiation grafting process for preparing separator membranes for electrochemical cells
GB8416965D0 (en) Fabricating solar cells
DK160290D0 (da) Flertrins affinitetsproces til isolering af specifikke celler fra en celleblanding
EP0068763A3 (en) Recombinant monoclonal antibodies
DE3068728D1 (en) Solar cell modules
AU3388484A (en) Solar cell made from amorphous superlattice material
DE3273127D1 (en) Fuel cell system utilizing liquid electrolyte
GB8305243D0 (en) Ternary iii-v multicolour solar cells
AU565214B2 (en) Laser grooved solar cell
EP0318315A3 (en) Process for making thin film solar cell
IL86034A0 (en) Separator for electrochemical cells
EP0480565A3 (en) Separators for electrochemical cells
AU550146B2 (en) Single cell protein from sulfur energy sources
EP0469776A3 (en) Separators for electrochemical cells
EP0219791A3 (en) Process for culturing recombinant cells
GB2145880B (en) Horizontal battery holder for cylindrical cells
NZ211230A (en) In vitro diagnosis; separating viable cells by magnetism
AU2351484A (en) Acetylcholinesterase from cell culture
NZ220766A (en) Mammalian cell fusion mediated by specific cell fusion agents
GB2095025B (en) Acid electrolyte fuel cell

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC.